U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903103) titled 'Prickly Pear Pulp Powder Along With an Anti-inflammatory Diet in Patients Having Liver Fibrosis' on Sept. 02.
Brief Summary: This RCT will evaluate the 12-week therapeutic effects of prickly pear pulp powder lozenges (0.5, 1.0, and 1.5 g/day) combined with an anti-inflammatory diet in adults with liver fibrosis (F1-F3).
Changes in ALT, AST, ALP, GGT, bilirubin, and clinical outcomes will be assessed to determine its potential as a safe, affordable, and hepatoprotective nutraceutical.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Lipid Profile
Blood Glucose
Liver Enzymes
Intervention:
DIETARY_SUPPLEMENT: Expe...